These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12428841)

  • 21. Illness perception in patients with androgenetic alopecia and alopecia areata in China.
    Yu NL; Tan H; Song ZQ; Yang XC
    J Psychosom Res; 2016 Jul; 86():1-6. PubMed ID: 27302539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of
    Łukasik A; Kozicka K; Pisarek A; Wojas-Pelc A
    Postepy Dermatol Alergol; 2022 Aug; 39(4):708-713. PubMed ID: 36090736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of androgenetic alopecia.
    Tosti A; Camacho-Martinez F; Dawber R
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgenetic alopecia: does its presence change our perceptions?
    Karaman GC; Dereboy C; Dereboy F; Carman E
    Int J Dermatol; 2006 May; 45(5):565-8. PubMed ID: 16700793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The psychosocial consequences of androgenetic alopecia: a review of the research literature.
    Cash TF
    Br J Dermatol; 1999 Sep; 141(3):398-405. PubMed ID: 10583042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Young men's coping with androgenetic alopecia: acceptance counts when hair gets thinner.
    Kranz D
    Body Image; 2011 Sep; 8(4):343-8. PubMed ID: 21855434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The psychological effects of androgenetic alopecia in men.
    Cash TF
    J Am Acad Dermatol; 1992 Jun; 26(6):926-31. PubMed ID: 1607410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological characteristics of women with androgenetic alopecia: a controlled study.
    van der Donk J; Passchier J; Knegt-Junk C; van der Wegen-Keijser MH; Nieboer C; Stolz E; Verhage F
    Br J Dermatol; 1991 Sep; 125(3):248-52. PubMed ID: 1911317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychological effect, pathophysiology, and management of androgenetic alopecia in men.
    Stough D; Stenn K; Haber R; Parsley WM; Vogel JE; Whiting DA; Washenik K
    Mayo Clin Proc; 2005 Oct; 80(10):1316-22. PubMed ID: 16212145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evolution of alopecia areata with a male androgenetic alopecia pattern to sisaipho.
    Camacho F; García-Hernández M
    Eur J Dermatol; 2000 Mar; 10(2):133-4. PubMed ID: 10694313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia.
    Dhurat R; Chitallia J; May TW; Jayaraaman AM; Madhukara J; Anandan S; Vaidya P; Klenk A
    Skin Pharmacol Physiol; 2017; 30(6):298-305. PubMed ID: 29055953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: A pilot randomized controlled trial.
    Mapar MA; Shahriari S; Haghighizadeh MH
    J Cosmet Laser Ther; 2016 Dec; 18(8):452-455. PubMed ID: 27593381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America.
    Lulic Z; Inui S; Sim WY; Kang H; Choi GS; Hong W; Hatanaka T; Wilson T; Manyak M
    J Dermatol; 2017 Aug; 44(8):892-902. PubMed ID: 28370105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.
    Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
    J Am Acad Dermatol; 2010 Sep; 63(3):420-9. PubMed ID: 20619491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study.
    Yang CC; Hsieh FN; Lin LY; Hsu CK; Sheu HM; Chen W
    J Am Acad Dermatol; 2014 Feb; 70(2):297-302.e1. PubMed ID: 24184140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emotional Consequences of Finasteride: Fool's Gold.
    Ganzer CA; Jacobs AR
    Am J Mens Health; 2018 Jan; 12(1):90-95. PubMed ID: 26868914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of hair density and hair diameter to the appearance and progression of androgenetic alopecia in Japanese men.
    Ishino A; Takahashi T; Suzuki J; Nakazawa Y; Iwabuchi T; Tajima M
    Br J Dermatol; 2014 Nov; 171(5):1052-9. PubMed ID: 24981717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Original article: Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation.
    Jha AK; Udayan UK; Roy PK; Amar AKJ; Chaudhary RKP
    J Cosmet Dermatol; 2018 Jun; 17(3):313-318. PubMed ID: 28771982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know.
    Yip L; Rufaut N; Sinclair R
    Australas J Dermatol; 2011 May; 52(2):81-8. PubMed ID: 21605090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Female alopecia: the mediating effect of attachment patterns on changes in subjective health indicators.
    Schmidt S
    Br J Dermatol; 2003 Jun; 148(6):1205-11. PubMed ID: 12828750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.